In particular, the progressive muscle wasting, weakness, and loss of muscle mass observed in patients suffering from these diseases were shown to be accompanied by increased mRNA [39] and protein levels of TGFβ [40] in DMD. This evidence concerns the gene TGFB1 and Duchenne muscular dystrophy.